Updated Guidelines in the Management of Symptomatic Hyperparathyroidism

Thursday, May 12, 2022

1:30 PM – 1:50 PM

Location: Breakout Room 4-Aqua ABC (Level 3)

Speaker(s)

Aliya A. Khan, MD,FRCPC, FACP, FACE,FASBMR
Professor Of Clinical Medicine
McMaster University
Oakville, Ontario, Canada

Disclosure: Alexion (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Amgen (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Amolyt (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Ascendis (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Chugai (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Radius (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Research Grant (Status: Ongoing); Takeda (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing); Ultragenyx (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing)

PDF Slides

Learning Objectives:

Identify how to diagnose PHPT
Recognize the complications of PHPT
Learn how to manage PHPT

Participants should be aware of the following financial/non-financial relationships:

Aliya A. Khan, MD,FRCPC, FACP, FACE,FASBMR : Alexion (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium, Research Grant; Amgen (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium, Research Grant; Amolyt (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Research Grant; Ascendis (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Research Grant; Chugai (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium, Research Grant; Radius (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Research Grant; Takeda (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium, Research Grant; Ultragenyx (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium, Research Grant